Enhanced Transdermal Drug Delivery by Transfersome-Embedded Oligopeptide Hydrogel for Topical Chemotherapy of Melanoma
- PMID: 30183253
- DOI: 10.1021/acsnano.8b03800
Enhanced Transdermal Drug Delivery by Transfersome-Embedded Oligopeptide Hydrogel for Topical Chemotherapy of Melanoma
Abstract
Topical administration of anticancer drugs provides a potential chemotherapeutic modality with high patient compliance for cutaneous melanoma. However, the drug delivery efficiency is highly limited by physiological barriers from the skin to the tumor, which cannot acquire desired therapeutic efficacy. Herein, we propose a paintable oligopeptide hydrogel containing paclitaxel (PTX)-encapsulated cell-penetrating-peptide (CPP)-modified transfersomes (PTX-CTs) to enhance transdermal PTX delivery for topical melanoma treatment. After being plastered on the skin above the melanoma tumor, the PTX-CTs-embedded hydrogel (PTX-CTs/Gel) as a patch provided prolonged retention capacity of the PTX-CTs on the skin. The PTX-CTs with superior deformability could efficiently squeeze through the channels in the stratum coreum, and the surfactant components improved the fluidity of the lipid molecules in the stratum corneum to further enhance the skin permeation. Moreover, the CPP modification rendered the PTX-CT-enhanced penetration in the skin and tumor stroma as well as efficient transportation in the tumor cells. The PTX-CTs were shown to effectively slow the tumor growth in combination with the systemic chemotherapy using Taxol, the commercial PTX formulation on the xenograft B10F16 melanoma mouse model.
Keywords: cell-penetrating peptide; melanoma; oligopeptide hydrogel; transdermal drug delivery; transfersome.
Similar articles
-
Paclitaxel skin delivery by micelles-embedded Carbopol 940 hydrogel for local therapy of melanoma.Int J Pharm. 2020 Sep 25;587:119626. doi: 10.1016/j.ijpharm.2020.119626. Epub 2020 Jul 10. Int J Pharm. 2020. PMID: 32659404
-
A reconstituted thermosensitive hydrogel system based on paclitaxel-loaded amphiphilic copolymer nanoparticles and antitumor efficacy.Drug Dev Ind Pharm. 2017 Jun;43(6):972-979. doi: 10.1080/03639045.2017.1287718. Epub 2017 Feb 14. Drug Dev Ind Pharm. 2017. PMID: 28121206
-
Topical delivery of chemotherapeutic drugs using nano-hybrid hydrogels to inhibit post-surgical tumour recurrence.Biomater Sci. 2021 Jun 15;9(12):4356-4363. doi: 10.1039/d0bm01766c. Biomater Sci. 2021. PMID: 34127987
-
Skin Penetration Enhancement Strategies Used in the Development of Melanoma Topical Treatments.AAPS J. 2021 Jan 6;23(1):19. doi: 10.1208/s12248-020-00544-y. AAPS J. 2021. PMID: 33404992 Review.
-
Recent Advances in Chemical Composition and Transdermal Delivery Systems for Topical Bio-actives in Skin Cancer.Curr Top Med Chem. 2023;23(1):31-43. doi: 10.2174/1568026622666220902104906. Curr Top Med Chem. 2023. PMID: 36056871 Review.
Cited by
-
Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis.Acta Pharm Sin B. 2023 Nov;13(11):4417-4441. doi: 10.1016/j.apsb.2023.05.025. Epub 2023 May 26. Acta Pharm Sin B. 2023. PMID: 37969725 Free PMC article. Review.
-
Chiral Supramolecular Hydrogel Enhanced Transdermal Delivery of Sodium Aescinate to Modulate M1 Macrophage Polarization Against Lymphedema.Adv Sci (Weinh). 2024 Feb;11(5):e2303495. doi: 10.1002/advs.202303495. Epub 2023 Dec 1. Adv Sci (Weinh). 2024. PMID: 38037850 Free PMC article.
-
Fabrication and application of targeted ciprofloxacin nanocarriers for the treatment of chronic bacterial prostatitis.Int J Pharm X. 2024 Apr 18;7:100247. doi: 10.1016/j.ijpx.2024.100247. eCollection 2024 Jun. Int J Pharm X. 2024. PMID: 38706465 Free PMC article.
-
A sulfur dioxide polymer prodrug showing combined effect with doxorubicin in combating subcutaneous and metastatic melanoma.Bioact Mater. 2020 Nov 10;6(5):1365-1374. doi: 10.1016/j.bioactmat.2020.10.027. eCollection 2021 May. Bioact Mater. 2020. PMID: 33210029 Free PMC article.
-
Phytochemical Delivery Through Transferosome (Phytosome): An Advanced Transdermal Drug Delivery for Complementary Medicines.Front Pharmacol. 2022 Feb 23;13:850862. doi: 10.3389/fphar.2022.850862. eCollection 2022. Front Pharmacol. 2022. PMID: 35281927 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials